Literature DB >> 4655822

The fate of cyclamate in man and other species.

A G Renwick, R T Williams.   

Abstract

1. (14)C-labelled cyclamate has been administered to guinea pigs, rabbits, rats and humans. When given orally to these species on a cyclamate-free diet, cyclamate is excreted unchanged. In guinea pigs some 65% of a single dose is excreted in the urine and 30% in the faeces, the corresponding values for rats being 40 and 50%, for man, 30-50% and 40-60%, and for rabbits, 90 and 5%, the excretion being over a period of 2-3 days. 2. Cyclamate appears to be readily absorbed by rabbits but less readily by guinea pigs, rats and humans. 3. If these animals, including man, are placed on a diet containing cyclamate they develop the ability to convert orally administered cyclamate into cyclohexylamine and consequently into the metabolites of the latter. The extent to which this ability develops is variable, the development occurring more readily in rats than in rabbits or guinea pigs. In three human subjects, one developed the ability quite markedly in 10 days whereas two others did not in 30 days. Removal of the cyclamate from the diet caused a diminution in the ability to convert cyclamate into the amine. 4. In rats that had developed the ability to metabolize orally administered cyclamate, intraperitoneally injected cyclamate was not metabolized and was excreted unchanged in the urine. The biliary excretion of injected cyclamate in rats was very small, i.e. about 0.3% of the dose. 5. The ability of animals to convert cyclamate into cyclohexylamine appears to depend upon a continuous intake of cyclamate and on some factor in the gastrointestinal tract, probably the gut flora.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4655822      PMCID: PMC1174232          DOI: 10.1042/bj1290869

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Excretion and distribution of radioactive S35-cyclamate sodium (sucaryl sodium) in animals.

Authors:  J D TAYLOR; R K RICHARDS; J C DAVIN
Journal:  Proc Soc Exp Biol Med       Date:  1951-11

2.  Studies on synthetic sweetening agents. XIV. Metabolism of sodium cyclamate. 3. On metabolites of sodium cyclamate in human.

Authors:  S Kojima; H Ichibagase
Journal:  Chem Pharm Bull (Tokyo)       Date:  1969-12       Impact factor: 1.645

3.  Conversion of cyclamate to cyclohexylamine in rats.

Authors:  B L Oser; S Carson; E E Vogin; R C Sonders
Journal:  Nature       Date:  1968-10-12       Impact factor: 49.962

4.  Studies on synthetic sweetening agents. 13. Metabolism of sodium cyclamate. (2). Detection of metabolites of sodium cyclamate in the rabbit and rat by gas-liquid chromatography.

Authors:  S Kojima; H Ichibagase
Journal:  Chem Pharm Bull (Tokyo)       Date:  1968-09       Impact factor: 1.645

5.  The metabolism of cyclamates in rats.

Authors:  W C Wallace; E J Lethco; E A Brouwer
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

6.  Excretion of cyclohexylamine, a metabolite of cyclamate, in human urine.

Authors:  M Asahina; T Yamaha; K Watanabe; G Sarrazin
Journal:  Chem Pharm Bull (Tokyo)       Date:  1971-03       Impact factor: 1.645

7.  Cyclohexylamine excretors among human volunteers given cyclamate.

Authors:  J S Leahy; T Taylor; C J Rudd
Journal:  Food Cosmet Toxicol       Date:  1967-10

8.  Studies on synthetic sweetening agents. 8. Cyclohexylamine, a metabolite of sodium cyclamate.

Authors:  S Kojima; H Ichibagase
Journal:  Chem Pharm Bull (Tokyo)       Date:  1966-09       Impact factor: 1.645

9.  Biliary excretion of foreign compounds. Benzene and its derivatives in the rat.

Authors:  M M Abou-El-Makarem; P Millburn; R L Smith; R T Williams
Journal:  Biochem J       Date:  1967-12       Impact factor: 3.857

10.  The role of the gut flora in the metabolism of cyclamate.

Authors:  B S Drasar; A G Renwick; R T Williams
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

View more
  7 in total

1.  Improvement of physicochemical properties of an antiepileptic drug by salt engineering.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Raghu Samy; Vilayat A Sayeed; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2012-05-17       Impact factor: 3.246

2.  The metabolites of cyclohexylamine in man and certain animals.

Authors:  A G Renwick; R T Williams
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

3.  The role of the gut flora in the metabolism of cyclamate.

Authors:  B S Drasar; A G Renwick; R T Williams
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

4.  Treatment with Atorvastatin During Vascular Remodeling Promotes Pericyte-Mediated Blood-Brain Barrier Maturation Following Ischemic Stroke.

Authors:  Yirong Yang; Lisa Y Yang; Victor M Salayandia; Jeffrey F Thompson; Michel Torbey; Yi Yang
Journal:  Transl Stroke Res       Date:  2021-01-09       Impact factor: 6.829

5.  Determination of cyclamate in urine by derivatized gas chromatography-mass spectrometry.

Authors:  Mohd Idris; Deepak Middha; Shaik N Rasool; Sudhir K Shukla; Tulsidas R Baggi
Journal:  J Pharm Bioallied Sci       Date:  2013-01

Review 6.  The gut microbiota: a major player in the toxicity of environmental pollutants?

Authors:  Sandrine P Claus; Hervé Guillou; Sandrine Ellero-Simatos
Journal:  NPJ Biofilms Microbiomes       Date:  2016-05-04       Impact factor: 7.290

7.  Antibody transcytosis across brain endothelial-like cells occurs nonspecifically and independent of FcRn.

Authors:  John S Ruano-Salguero; Kelvin H Lee
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.